Interim Financial Reporting (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Sales	$ 10,141,000	$ 8,787,000	$ 30,390,000	$ 26,287,000
Common stock equivalents excluded from calculation of diluted earnings per share	102,435		112,427	52,017
International [Member]
Sales			$ 432,000	$ 297,000